Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Drops By 33.3%

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 200 shares, a decrease of 33.3% from the August 31st total of 300 shares. Based on an average daily trading volume, of 1,700 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 1,700 shares, the days-to-cover ratio is currently 0.1 days.

BioSyent Stock Up 0.6%

Shares of BioSyent stock opened at $8.45 on Tuesday. The firm’s 50 day moving average price is $8.48 and its 200-day moving average price is $8.27. BioSyent has a 52-week low of $6.49 and a 52-week high of $8.85.

BioSyent Company Profile

(Get Free Report)

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.

Read More

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.